Starpharma Holdings Limited Stock Other OTC
Equities
SPHRY
US8555631022
Pharmaceuticals
Sales 2022 | 5.16M 3.36M | Sales 2023 | 4.21M 2.74M | Capitalization | 127M 82.75M |
---|---|---|---|---|---|
Net income 2022 | -16M -10.4M | Net income 2023 | -15M -9.75M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 27.13M | Net cash position 2023 | 26.91M 17.5M | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.68% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | Jan. 07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 23-04-02 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 22-03-31 |
Robert Thomas
CHM | Chairman | 79 | 13-12-03 |
David McIntyre
BRD | Director/Board Member | 53 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+25.73% | 672B | |
+25.87% | 570B | |
-5.02% | 360B | |
+16.81% | 321B | |
+8.44% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.79% | 149B |